LabCorp Launches New COVID-19 Clinical Trial Site
To connect patients with US research trials; streamlining recruitment into studies to speed research.
June 2, 2020
by contractpharma
Labcorp Accelerates Adoption of Decentralized Clinical Trials
LabCorp’s drug development business, Covance, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as hybrid and virtual clinical trials.
June 1, 2020
by contractpharma
Covance Unveils New R&D Center in Shanghai
LabCorp’s Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility in the Asia Pacific region.
September 19, 2019
by contractpharma
Covance unveils new R&D center in Shanghai
Inauguration Ceremony Highlights World-Class, Comprehensive Drug Development Capabilities and More Than Two Decades of Growth in China
September 17, 2019
by biospectrumasia
Covance Launches Laboratory Data Management Functional Service
LabCorp said that its Covance drug development business has launched a laboratory solution within its functional service provider (FSPx) offering.
September 6, 2019
by contractpharma
Covance Launches Lab Solution within FSPx Offering
Program comprises a clinical analytics service and clinical operations capabilities.
August 30, 2019
by contractpharma
Covance recieves Frost and Sullivan Award
Covance has recieved 2014 Frost Sullivan Asia Pacific CRO Growth Excellence Leadership AwardSingapore:Covance, a global
October 23, 2018
by biospectrumasia
Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development
LabCorp®announced today that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.
March 12, 2018
by biospace